Cannabis Stocks Dive
Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
A Drug Enforcement Administration (DEA) judge has ordered the agency to respond to new allegations that it opposes the Biden ...
The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...
Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling ...
Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence ...
Despite legalization disappointments from 2024, the cannabis industry is far from standing still as the calendar changes over ...
DEA STYMIED MARIJUANA DRUG DEVELOPMENT - HOWEVER FDA MOVING FORWARD ON CANNABIS DRUG DEVELOPMENT FOR HUNTINGTON'S DISEASE "We ...
The latest announcement is out from Village Farms International ( (VFF) ).
Here are our cannabis industry predictions for 2025: The process to reclassify marijuana as a Schedule 3 drug must end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback